In reply to Jim Fraser:
> Has anyone got experience of Dupruytrens and then been on treatments for other conditions involving hormones or hormone antagonists?
I think you're making a number of questionable assumptions here.
What if the key factor is the amount of stress and damage, and this is weight-related? Do we have comparable female cohort who have been climbing long enough? (I'm perfectly aware, indeed have personal experience, of women who have been climbing hard for decades, but it's fair to say that it's a small sample. There will certainly a suitable cohort in a decade or so)
Even if there's a clear sex bias, is it hormonally based? And even if it is, would the disease, once started, be treatable by hormonal interventions? Given the side effects, could this justified for such a relatively benign condition, usually treatable in other ways?
Apart from that, it's an interesting idea!
Edit: It occurred to me that the interesting question would be the pre- and post-menopausal incidence. A quick google suggests it is more common in postmenopausal women but then it's also related to age generally, so that would take some careful study design to sort out.
I thought it was more common in fishwives but maybe I'm thinking of Raynaud's...
Post edited at 10:14